Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 hydrocortisone acetate suppository study in ulcerative colitis of the rectum
2019-003596-19Phase 3Completed
- Sponsor
- Cristcot
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydrocortisone in autoimmune colitis (3 arms), sponsored by Cristcot. Primary endpoint: Clinical remission at End of Treatment. Started Jul 2020; status: completed.
02
Drugs
hydrocortisone
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2019-003596-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003596-19.